Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.53% |
| 2 | Healthcare | 9.76% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.41% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
2951
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $9.37M | ﹤0.01% |
151,014
+49,639
| +49% | +$3.04M |
|
2952
GameStop
GME
$8.33B
| $9.36M | ﹤0.01% |
224,628
-110,372
| -33% | -$3.26M |
|
2953
Methanex
MEOH
$4.17B
| $9.35M | ﹤0.01% |
171,428
-7,296
| -4% | -$357K |
|
2954
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $9.32M | ﹤0.01% |
319,068
-34,072
| -10% | -$1.02M |
|
2955
Greif
GEF
$5.03B
| $9.31M | ﹤0.01% |
143,093
+35,375
| +33% | +$2.11M |
|
|
TEN
2956
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $9.3M | ﹤0.01% |
507,848
+349,868
| +221% | +$5.02M |
|
2957
Iovance Biotherapeutics
IOVA
$3.05B
| $9.3M | ﹤0.01% |
558,750
+305,175
| +120% | +$4.72M |
|
2958
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
| $9.29M | ﹤0.01% |
151,343
+3,958
| +3% | +$253K |
|
|
ENDP
2959
DELISTED
Endo International plc
ENDP
| $9.29M | ﹤0.01% |
4,019,573
-500,194
| -11% | -$1.47M |
|
2960
PIMCO Municipal Income Opportunities Active ETF
MINO
$754M
| $9.27M | ﹤0.01% |
200,000
| – | – |
|
|
OPLN
2961
Openlane
OPLN
$4.34B
| $9.25M | ﹤0.01% |
512,411
-149,918
| -23% | -$2.4M |
|
|
PDS
2962
Precision Drilling
PDS
$1.08B
| $9.25M | ﹤0.01% |
125,079
+43,237
| +53% | +$2.29M |
|
|
CHX
2963
DELISTED
ChampionX
CHX
| $9.24M | ﹤0.01% |
377,521
-261,898
| -41% | -$6.06M |
|
2964
John Wiley & Sons Class A
WLY
$2.63B
| $9.24M | ﹤0.01% |
174,151
-2,790
| -2% | -$147K |
|
2965
First Trust Multi Cap Value AlphaDEX Fund
FAB
$178M
| $9.23M | ﹤0.01% |
123,640
+26,568
| +27% | +$1.98M |
|
|
CMBT
2966
CMB.TECH NV
CMBT
$4.92B
| $9.22M | ﹤0.01% |
872,575
-85,046
| -9% | -$844K |
|
2967
G-III Apparel Group
GIII
$1.41B
| $9.22M | ﹤0.01% |
340,911
-26,896
| -7% | -$732K |
|
|
ICPT
2968
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.22M | ﹤0.01% |
566,492
+372,527
| +192% | +$5.84M |
|
2969
Pathward Financial
CASH
$1.78B
| $9.21M | ﹤0.01% |
167,741
-8,050
| -5% | -$457K |
|
2970
Stewart Information Services
STC
$2B
| $9.21M | ﹤0.01% |
151,901
-549
| -0.4% | -$38.1K |
|
2971
Stepan Co
SCL
$1.48B
| $9.2M | ﹤0.01% |
93,063
-40,812
| -30% | -$4.41M |
|
2972
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $9.2M | ﹤0.01% |
169,831
-750
| -0.4% | -$41.6K |
|
2973
TIM SA
TIMB
$8.69B
| $9.2M | ﹤0.01% |
634,184
+241,494
| +61% | +$3.05M |
|
2974
Canadian Solar
CSIQ
$1.04B
| $9.19M | ﹤0.01% |
259,944
+31,540
| +14% | +$952K |
|
2975
Anavex Life Sciences
AVXL
$316M
| $9.18M | ﹤0.01% |
745,607
+388,392
| +109% | +$4.78M |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.